Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastoma (Q35800532)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 2006

edit

Language	Label	Description	Also known as
English	Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastoma	scientific article published on January 2006

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PMC publication ID

1871923

retrieved

10 August 2017

title

Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastoma (English)

1 reference

stated in

Europe PubMed Central

PMC publication ID

1871923

retrieved

10 August 2017

main subject

phase I clinical trial

0 references

glioblastoma

1 reference

based on heuristic

inferred from title

author

Nadine Martin-Duverneuil

series ordinal

7

object named as

Nadine Martin-Duverneuil

0 references

Florence Laigle-Donadey

series ordinal

2

object named as

Florence Laigle-Donadey

0 references

Marc Sanson

series ordinal

8

object named as

Marc Sanson

1 reference

stated in

Europe PubMed Central

PMC publication ID

1871923

retrieved

10 August 2017

Jean-Yves Delattre

series ordinal

13

object named as

Jean-Yves Delattre

1 reference

stated in

Europe PubMed Central

PMC publication ID

1871923

retrieved

10 August 2017

Sophie Taillibert

series ordinal

10

object named as

Sophie Taillibert

1 reference

stated in

Europe PubMed Central

PMC publication ID

1871923

retrieved

10 August 2017

Antoine F Carpentier

series ordinal

14

object named as

Antoine F Carpentier

1 reference

stated in

Europe PubMed Central

PMC publication ID

1871923

retrieved

10 August 2017

author name string

Alexandre Carpentier

series ordinal

1

1 reference

stated in

Europe PubMed Central

PMC publication ID

1871923

retrieved

10 August 2017

Sarah Zohar

series ordinal

3

1 reference

stated in

Europe PubMed Central

PMC publication ID

1871923

retrieved

10 August 2017

Laurent Capelle

series ordinal

4

1 reference

stated in

Europe PubMed Central

PMC publication ID

1871923

retrieved

10 August 2017

Anthony Behin

series ordinal

5

1 reference

stated in

Europe PubMed Central

PMC publication ID

1871923

retrieved

10 August 2017

Annick Tibi

series ordinal

6

1 reference

stated in

Europe PubMed Central

PMC publication ID

1871923

retrieved

10 August 2017

Lucette Lacomblez

series ordinal

9

1 reference

stated in

Europe PubMed Central

PMC publication ID

1871923

retrieved

10 August 2017

Louis Puybasset

series ordinal

11

1 reference

stated in

Europe PubMed Central

PMC publication ID

1871923

retrieved

10 August 2017

Remy Van Effenterre

series ordinal

12

1 reference

stated in

Europe PubMed Central

PMC publication ID

1871923

retrieved

10 August 2017

publication date

1 January 2006

1 reference

stated in

Europe PubMed Central

PMC publication ID

1871923

retrieved

10 August 2017

published in

Neuro-Oncology

1 reference

stated in

Europe PubMed Central

PMC publication ID

1871923

retrieved

10 August 2017

volume

8

1 reference

stated in

Europe PubMed Central

PMC publication ID

1871923

retrieved

10 August 2017

issue

1

1 reference

stated in

Europe PubMed Central

PMC publication ID

1871923

retrieved

10 August 2017

page(s)

60-66

1 reference

stated in

Europe PubMed Central

PMC publication ID

1871923

retrieved

10 August 2017

cites work

Successful combination of local CpG-ODN and radiotherapy in malignant glioma

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871923

retrieved

11 July 2018

Use of CpG oligodeoxynucleotides as immunoprotective agents

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871923

retrieved

11 July 2018

Comparative pharmacokinetics of 14C-sucrose in RG-2 rat gliomas after intravenous and convection-enhanced delivery

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871923

retrieved

11 July 2018

Antitumor applications of stimulating toll-like receptor 9 with CpG oligodeoxynucleotides

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871923

retrieved

11 July 2018

Neuronal injury mediated via stimulation of microglial toll-like receptor-9 (TLR9).

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871923

retrieved

11 July 2018

CpG-oligonucleotides for cancer immunotherapy : review of the literature and potential applications in malignant glioma

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871923

retrieved

11 July 2018

Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871923

retrieved

11 July 2018

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871923

retrieved

11 July 2018

Oligodeoxynucleotides containing CpG motifs can induce rejection of a neuroblastoma in mice

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871923

retrieved

11 July 2018

Autoreactive T cells persist in rats protected against experimental autoimmune encephalomyelitis and can be activated through stimulation of innate immunity

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871923

retrieved

25 September 2018

Successful treatment of intracranial gliomas in rat by oligodeoxynucleotides containing CpG motifs.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871923

retrieved

25 September 2018

Response criteria for phase II studies of supratentorial malignant glioma

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871923

retrieved

25 September 2018

Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16443949

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Distribution and stability of antisense phosphorothioate oligonucleotides in rodent brain following direct intraparenchymal controlled-rate infusion

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16443949

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16443949

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16443949

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1215/S1522851705000475

1 reference

stated in

Europe PubMed Central

PMC publication ID

1871923

retrieved

10 August 2017

PMC publication ID

1871923

1 reference

stated in

Europe PubMed Central

PMC publication ID

1871923

retrieved

10 August 2017

PubMed publication ID

16443949

1 reference

stated in

Europe PubMed Central

PMC publication ID

1871923

retrieved

10 August 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35800532&oldid=2015158629"